BioSpace News Archive

Pharm Country

Actinium Highlights Successful Administration of Targeted Radiotherapy Iomab-B Across Various BMT Centers with Ease and Without Increasing Radiation Exposure Risks

Actinium Pharmaceuticals, Inc. today announced that two posters detailing positive clinical experiences are being presented at the 48th Annual Oncology Nursing Society (ONS) Congress, which is being held on April 26–30, 2023, in San Antonio, Texas.

April 28, 2023

·

10 min read

Cybin to Participate at the 26th Annual Milken Institute Global Conference

Cybin Inc. today announced that Doug Drysdale, Cybin’s Chief Executive Officer, will be speaking at the 26th Annual Milken Institute Global Conference on a panel entitled “Progress and Innovation: The Dawning of a New Day in Treating Mental Health.”

April 28, 2023

·

7 min read

Genetown

Astria Therapeutics to Present STAR-0215 at the 13th C1-Inhibitor Deficiency and Angioedema Workshop

Astria Therapeutics, Inc. today announced that it will present information on STAR-0215 and its development in two presentations at the 13th C1-Inhibit Deficiency and Angioedema Workshop in Budapest, Hungary.

April 28, 2023

·

1 min read

Biotech Bay

First Comprehensive Care Plan to Prevent Preeclampsia Published in the American Journal of Obstetrics and Gynecology

A new special report published in the American Journal of Obstetrics and Gynecology provides a groundbreaking approach to preeclampsia, one of the most pressing issues in maternal health and will translate the prediction of risk into prevention of disease.

April 28, 2023

·

8 min read

BioMidwest

Urologists Explore the Impact of the Dobbs Decision on Men Seeking Vasectomies

What are the impacts of the Dobbs decision on the number of men seeking a vasectomy? What are the long-term effects of the Dobbs decision for urologists? What types of men are more likely to get a vasectomy after the ruling?

April 28, 2023

·

2 min read

Deals

ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering

ENDRA Life Sciences Inc. announced today that it has priced an underwritten public offering of 3,750,000 shares of its common stock and warrants to purchase 1,875,000 shares of its common stock.

April 28, 2023

·

6 min read

BioMidwest

Urologists Explore the Validity of Urologic Information on Social Media

Is online information about recurrent UTIs reliable? How does TikTok relate to medical misinformation? Is YouTube helpful for patient education?

April 28, 2023

·

2 min read

BioMidwest

Urologists Explore Treatments for Recurrent UTIs, the Financial Burden of UTIs and UTI Information on Social Media

What is MV140 and how does it help prevent rUTI? How many women experience financial toxicity when getting treated for urinary incontinence?

April 28, 2023

·

2 min read

Business

Y-mAbs to Announce First Quarter 2023 Financial and Operating Results on May 8, 2023

Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB) today announced that it will report its financial results for the quarter ended March 31, 2023, on Monday, May 8, 2023, after the close of the U.S. financial markets.

April 28, 2023

·

4 min read

Biotech Beach

Promis Diagnostics’ EarlyTect BCD Receives FDA Breakthrough Device Designation for Bladder Cancer Detection

Promis Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to EarlyTect BCD as a non-invasive, urine-based diagnosis of bladder cancer from patients with hematuria.

April 28, 2023

·

3 min read